A positive review of current and future chronic lymphocytic leukemia treatments
George Follows, MA, BM, BCh, PhD, FRCP, FRCPath from Cambridge University, Cambridge, UK provides us with an update on current and future chronic lymphocytic leukemia (CLL) treatments that have been presented at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA. Prof. Follows begins by reviewing the positive results seen using currently available CLL drugs used on their own and in combination with other therapies. He also gives an update on the latest CLL trials, including those on venetoclax and new combination therapies. Prof. Follows provides an example of an exciting new trial testing alemtuzumab antibody treatment in combination with venetoclax. More CLL trials and drugs are in the pipeline and, while getting these treatments into practice will take time, the results will be worth it.
Видео A positive review of current and future chronic lymphocytic leukemia treatments канала Patient Power Europe
Видео A positive review of current and future chronic lymphocytic leukemia treatments канала Patient Power Europe
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Chronische lymphatische Leukämie Highlights von ASH 2016How far are we from a cure for CLL?Treatment for Chronic lymphocytic leukaemia (CLL) and Small lymphocytic lymphoma (SLL)?As novidades publicadas no maior congresso de hematologia do mundo: ASH 2016Νέοι παράγοντες και θεραπευτικοί συνδυασμοί ενισχύουν τη μάχη ενάντια στη CLLWhat is low-grade non-Hodgkin lymphoma?Leucémie Lymphoïde Chronique : une maladie hétérogène nécéssitant un traitement personnaliséChronic Lymphocytic Leukemia (CLL) - Mayo ClinicCome convivere al meglio con la leucemia limfocitara cronicaThe Healthcare Interoperability HubWie wird eine CLL diagnostiziert und welche Rolle spielen Mutationen bei der Therapiewahl?Leucemia Linfocítica Crónica (LLC)Was chronische lymphatische Leukämie Patienten selbst für das eigene Wohlbefinden tun könnenNeue Entwicklungen in der chronischen lymphatischen Leukämie von ASH 2016Factores que influenciam a escolha de tratamento para a leucemia linfocítica crónica (LLC)Fortschritte in der Behandlung des follikulären LymphomsBehandlung der CLL - welche Faktoren berücksichtigt werden und wann behandelt wirdNon-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathologyDie Behandlung der chronischen lymphatischen Leukämie mit ChemoimmuntherapieNICE approve ibrutinib in the UK